WHO ICTRP trial

Effect of analgesia with intravenous remifentanil versus intravenous pethidine…

IRCT20191219045802N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting

Key facts

Trial ID IRCT20191219045802N1
Public title Effect of analgesia with intravenous remifentanil versus intravenous pethidine on maternal and neonatal complications and maternal satisfaction with labor during active phase of labor
Scientific title Effect of analgesia with intravenous remifentanil versus intravenous pethidine on maternal and neonatal complications and maternal satisfaction with labor during active phase of labor
Primary sponsor Tabriz University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Recruiting
Study type interventional
Phase 2-3
Countries Iran (Islamic Republic of)
Conditions Labour Analgesia.
Interventions Intervention 1: Intervention group: Pittidine intravenous analgesia. In the anesthetic group with pethidine, 25 mg / day of the drug will be diluted with 4 cc distilled water (2-3 minutes). Intervention 2: Control group: Remifentanil…
Registration date Jul 29, 2020
Target size 120
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations